Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Gross Profit Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual gross profit in 2021 was 11.23 Million USD , up 584.77% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly gross profit in 2022 Q2 was 2.89 Million USD , down -13.65% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a annual gross profit of -2.31 Million USD in annual gross profit 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly gross profit of 3.34 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly gross profit of 11.23 Million USD for 2021 FY, up 584.77% from previous quarter.

Annual Gross Profit Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Gross Profit of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Gross Profit Gross Profit Growth
2021 11.23 Million USD 584.77%
2020 -2.31 Million USD 0.0%

Peer Gross Profit Comparison of Clarus Therapeutics Holdings, Inc.

Name Gross Profit Gross Profit Difference
AstraZeneca PLC 34.69 Billion USD 99.968%
Bristol-Myers Squibb Company PFD CONV 2 34.31 Billion USD 99.967%
CSPC Pharmaceutical Group Limited 30.13 Billion USD 99.963%
Novartis AG 34.18 Billion USD 99.967%
PT Kalbe Farma Tbk. 743.47 Million USD 98.489%